News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
576,816 Results
Type
Article (45928)
Company Profile (182)
Press Release (530706)
Section
Business (162149)
Career Advice (2450)
Deals (30299)
Drug Delivery (108)
Drug Development (74561)
Employer Resources (149)
FDA (16208)
Job Trends (12740)
News (290997)
Policy (31297)
Tag
Academia (2428)
Alliances (40768)
Alzheimer's disease (1298)
Approvals (16118)
Artificial intelligence (133)
Bankruptcy (310)
Best Places to Work (9666)
Biotechnology (121)
Breast cancer (117)
Cancer (1093)
Cardiovascular disease (97)
Career advice (2035)
Cell therapy (247)
Clinical research (59189)
Collaboration (371)
Compensation (200)
COVID-19 (2594)
C-suite (96)
Data (1083)
Diabetes (159)
Diagnostics (5459)
Drug pricing (97)
Earnings (62880)
Employer resources (137)
Events (86488)
Executive appointments (281)
FDA (16746)
Funding (304)
Gene therapy (191)
GLP-1 (666)
Government (3983)
Healthcare (15928)
Infectious disease (2683)
Inflammatory bowel disease (104)
Interviews (452)
IPO (14777)
Job creations (3418)
Job search strategy (1707)
Layoffs (456)
Legal (7428)
Lung cancer (179)
Manufacturing (180)
Medical device (11712)
Medtech (11715)
Mergers & acquisitions (15597)
Metabolic disorders (450)
Neuroscience (1577)
NextGen Class of 2024 (5323)
Non-profit (3506)
Northern California (1434)
Obesity (264)
Opinion (207)
Patents (105)
People (47258)
Phase I (17810)
Phase II (25702)
Phase III (20480)
Pipeline (466)
Policy (86)
Postmarket research (2598)
Preclinical (7336)
Radiopharmaceuticals (219)
Rare diseases (226)
Real estate (4866)
Regulatory (21264)
Research institute (2184)
Resumes & cover letters (411)
Southern California (1176)
Startups (3065)
United States (12280)
Vaccines (628)
Weight loss (216)
Date
Today (78)
Last 7 days (646)
Last 30 days (3554)
Last 365 days (33402)
2024 (30658)
2023 (37000)
2022 (47677)
2021 (51296)
2020 (48534)
2019 (39661)
2018 (29998)
2017 (29823)
2016 (28120)
2015 (31149)
2014 (24404)
2013 (20009)
2012 (21620)
2011 (22336)
2010 (20696)
Location
Africa (705)
Arizona (144)
Asia (34794)
Australia (5802)
California (3111)
Canada (1057)
China (240)
Colorado (131)
Connecticut (157)
Europe (82741)
Florida (421)
Georgia (108)
Illinois (285)
Indiana (162)
Maryland (547)
Massachusetts (2391)
Michigan (127)
Minnesota (221)
New Jersey (901)
New York (868)
North Carolina (674)
Northern California (1434)
Ohio (114)
Pennsylvania (756)
South America (1091)
Southern California (1176)
Texas (415)
Washington State (336)
576,816 Results for "dipharma francis s r l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USAThe Company expands its range of CGMP services to include small-scale commercial APIs
Dipharma Francis S.r.l. proudly announced that Dipharma Inc., its US facility located in Kalamazoo, MI, has been inspected by the U.S. Food and Drug Administration and has received the Establishment Inspection Report, satisfactorily closing the inspection process.
May 7, 2024
·
3 min read
Dipharma Receives the 2nd GMP Certification from Brazilian ANVISA
Dipharma Francis S.r.l., a leading Contract Development and Manufacturing Organization and a global manufacturer of Active Pharmaceutical Ingredients, announced another new production site of the Group, thefacility located in Caronno Pertusella, near Milan, has received the Good Manufacturing Practice certification - CBPF - from the Regulatory Authority of Brazil, ANVISA.
October 26, 2023
·
2 min read
Dipharma expands its Italian R&D Center to increase its analytical services
Dipharma Francis S.r.l. announced the completion of the expansion of its Research and Development Center for small molecules at its Headquarters located in Baranzate, close to Milan, in the North of Italy.
April 4, 2023
·
3 min read
Dipharma completes second phase of CGMP expansion at its Kalamazoo site
Dipharma Francis S.r.l. announced the completion of the second phase of expansion of its American site, Dipharma Inc., located in Kalamazoo, MI.
February 10, 2023
·
3 min read
Dipharma receives GMP certification from Brazilian ANVISAThe Baranzate site (Italy) is the first Dipharma manufacturing facility to receive Anvisa certification
Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active Pharmaceutical Ingredients, announced today that its production site, located in Baranzate, just outside Milan (Italy), has received the Good Manufacturing Practice (GMP) certification, CBPF (Certificado de Boas Práticas de Fabricação), from the Regulatory Authority of Brazil, ANVISA (Agência Nacional de Vigilância Sanitária).
December 1, 2022
·
2 min read
Dipharma Receives Regulatory Authorization for the New Line at Its cGMP Pilot Plant
Dipharma Francis S.r.l. announced that the Italian Medicines Agency approved the brand-new production line at the cGMP pilot plant suite, located in its facility of Mereto di Tomba.
October 6, 2022
·
3 min read
Deals
Frontage Laboratories Acquires Accelera S.r.l.'s Bioanalytical and DMPK Businesses
Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
January 2, 2024
·
5 min read
Genetown
Broken String Biosciences and the Francis Crick Institute Collaborate to Advance ALS Research
Broken String Biosciences announced it has entered a research collaboration with the Francis Crick Institute, a world-leading biomedical discovery institute dedicated to understanding the biology underlying health and disease.
May 7, 2024
·
3 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
FDA
Analog Pharma and Dipharma announce US FDA approval of abbreviated new drug application (ANDA) of 20 mg generic Nitisinone capsules (temperature stable)
Analog Pharma (member of Duchesnay Pharmaceutical Group, hereafter “Analog”) and Dipharma S.A. (“Dipharma”) are pleased to announce that their 20 mg nitisinone abbreviated new drug application (ANDA) has received final approval from the U.S. Food and Drug Administration.
May 31, 2023
·
8 min read
1 of 57,682
Next